Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence ; volume:15 ; number:1 ; day:25 ; month:7 ; year:2024 ; pages:1-11 ; date:12.2024
Nature Communications ; 15, Heft 1 (25.7.2024), 1-11, 12.2024
- Urheber
-
Stapley, Jacob N.
Hamley, Jonathan I. D.
Walker, Martin
Dixon, Matthew A.
Colebunders, Robert
Basáñez, Maria-Gloria
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-50582-9
- URN
-
urn:nbn:de:101:1-2410102112337.866591402493
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stapley, Jacob N.
- Hamley, Jonathan I. D.
- Walker, Martin
- Dixon, Matthew A.
- Colebunders, Robert
- Basáñez, Maria-Gloria
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
Report of the first international workshop on onchocerciasis-associated epilepsy
Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
Report of the first international workshop on onchocerciasis-associated epilepsy
Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed